Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation.

Transl Oncol · 2022 · PMC8695353 · PMID 34942534

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Loss of CSPG4 resulted in a highly significant reduction in the ability of all three cell lines to form spheroids ( Fig. 3 B–D ). .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.